Ram Aiyar

Ram Aiyar serves as the Chief Executive Officer and President, bringing nearly two decades of experience in the biotech and pharmaceutical industries. He holds a Master of Science and a Ph.D. in Electrical and Computer Engineering from Drexel University, as well as an MBA in Finance and Business Strategy from INSEAD. Aiyar’s career is marked by significant contributions across all stages of biotech development, from launch to clinical and commercialization. He has a proven track record in launching and building biotech startups. His previous roles include co-founder, Chief Financial Officer, and Chief Business Officer at Corvidia Therapeutics, where he led the company through its acquisition by Novo Nordisk for $2.1 billion. Aiyar was also an entrepreneur-in-residence at BioHealth Innovation (BHI) and began his scientific career in the immunology group at Janssen Pharmaceuticals. Additionally, he has held leadership positions in corporate development, finance, and strategy at FlowMetric Inc., Sofinnova Partners, and J.P. Morgan Chase.